Search PubMed⌕ Search

PubMed · 11529319

Humoral coding and decoding.

Abstract

Humoral communication systems are dynamically regulated. Most hormones are released in a pulsatile or burst-like manner into the bloodstream. It is well known that information coded in the frequency and amplitude of secretory pulses allows for the differential regulation of specific target cell function and structure. However, despite intensive study of transmembrane signalling relatively little is known about how the temporal dynamics of extracellular humoral stimuli specifically regulates the temporal pattern of intracellular signalling pathways, such as Ca2+-dependent signalling. Repetitive spikes of Ca2+ encode this information in their amplitude, duration and frequency, and are in turn decoded into the pattern of gene expression and phosphorylation of target proteins. Using a mathematical model for G protein-coupled Ca2+ signalling and information-theoretic approaches to stimulus reconstruction we have systematically quantified the amount of information coded in the Ca2+-signal about the dynamics of the stimulus, which allows us to explore the temporal bandwidth of transmembrane signalling. These in silico approaches permit us to differentiate the amount of information coded in the frequency, temporal precision, amplitude and the complete Ca2+-signal. This may open an avenue to the quantification of information flow and processing in the intra- and intercellular coding and decoding machinery.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Prank, M Kropp, G Brabant. 2001. Humoral coding and decoding.. https://doi.org/10.1002/0470846674.ch9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Superior colliculus firing changes after lesion or electrical stimulation of the subthalamic nucleus in the rat.

Recent data have suggested a critical role for the basal ganglia in the remote control of epileptic seizures. In particular, it has been shown that inhibition of either substantia nigra pars reticulata or subthalamic nucleus as well as activation of the superior colliculus suppresses generalized seizures in several animal models. It was previously shown that high frequency stimulation of the subthalamic nucleus, thought to act as functional inhibition, stopped ongoing non-convulsive generalized seizures in rats. In order to determine whether high frequency stimulation of the subthalamic nucleus involved an activation of superior colliculus neurons, we examined the effects of subthalamic nucleus manipulation, by either high frequency stimulation or chemical lesion, on the spontaneous electrical activity of superior colliculus neurons. Acute high frequency stimulation of the subthalamic nucleus (frequency 130 Hz) induced an immediate increase of unitary activity in 70% of responding cells, mainly located within the deep layers, whereas a reduction was observed in the remaining 30%. The latter responses are dependent on the intensity and frequency of the stimulation. Unilateral excitotoxic lesion of the subthalamic nucleus induced a delayed and transient decrease of superior colliculus activity. Our data suggest that high frequency stimulation of the subthalamic nucleus suppresses generalised epileptic seizures through superior colliculus activation.

Action Potentials↗

FXYD7 is a brain-specific regulator of Na,K-ATPase alpha 1-beta isozymes.

Recently, corticosteroid hormone-induced factor (CHIF) and the gamma-subunit, two members of the FXYD family of small proteins, have been identified as regulators of renal Na,K-ATPase. In this study, we have investigated the tissue distribution and the structural and functional properties of FXYD7, another family member which has not yet been characterized. Expressed exclusively in the brain, FXYD7 is a type I membrane protein bearing N-terminal, post-translationally added modifications on threonine residues, most probably O-glycosylations that are important for protein stabilization. Expressed in Xenopus oocytes, FXYD7 can interact with Na,K-ATPase alpha 1-beta 1, alpha 2-beta 1 and alpha 3-beta 1 but not with alpha-beta 2 isozymes, whereas, in brain, it is only associated with alpha 1-beta isozymes. FXYD7 decreases the apparent K(+) affinity of alpha 1-beta 1 and alpha 2-beta 1, but not of alpha 3-beta1 isozymes. These data suggest that FXYD7 is a novel, tissue- and isoform-specific Na,K-ATPase regulator which could play an important role in neuronal excitability.

Action Potentials↗